Search hospitals

>

Utah

>

Salt Lake City

Huntsman Cancer Institute/University of Utah

Claim this profile

Salt Lake City, Utah 84112

Global Leader in Cancer

Global Leader in Breast Cancer

Conducts research for Lung Cancer

Conducts research for Melanoma

Conducts research for Pancreatic Cancer

1129 reported clinical trials

81 medical researchers

Photo of Huntsman Cancer Institute/University of Utah in Salt Lake CityPhoto of Huntsman Cancer Institute/University of Utah in Salt Lake CityPhoto of Huntsman Cancer Institute/University of Utah in Salt Lake City

Summary

Huntsman Cancer Institute/University of Utah is a medical facility located in Salt Lake City, Utah. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Melanoma, Pancreatic Cancer and other specialties. Huntsman Cancer Institute/University of Utah is involved with conducting 1,129 clinical trials across 864 conditions. There are 81 research doctors associated with this hospital, such as Heloisa Soares, Michael Pulsipher, MD, Sunil Sharma, and Theresa Werner, MD.

Area of expertise

1

Cancer

Global Leader

Huntsman Cancer Institute/University of Utah has run 171 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
KRAS positive
2

Breast Cancer

Global Leader

Huntsman Cancer Institute/University of Utah has run 146 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
HER2 negative
Stage III

Top PIs

Clinical Trials running at Huntsman Cancer Institute/University of Utah

Skin Cancer

Breast Cancer

Esophageal cancer

Breast cancer

Lung Cancer

Uterine Cancer

Multiple Myeloma

Prostate Cancer

Cancer

Ovarian Cancer

Image of trial facility.

Cemiplimab + Surgery

for Advanced Skin Cancer

This phase III trial compares the effect of adding cemiplimab to standard therapy (surgery with or without radiation) versus standard therapy alone in treating patients with stage III/IV squamous cell skin cancer that is able to be removed by surgery (resectable) and that may have come back after a period of improvement (recurrent). The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cemiplimab has been approved for the treatment of skin cancer that has spread or that cannot be removed by surgery, but it has not been approved for the treatment of skin cancer than can be removed by surgery. Adding cemiplimab to the usual treatment of surgery with or without radiation may be more effective in treating patients with stage III/IV resectable squamous cell skin cancer than the usual treatment alone.

Recruiting

2 awards

Phase 3

7 criteria

Image of trial facility.

Radiation Therapy

for Brain Metastasis

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.

Recruiting

2 awards

Phase 3

12 criteria

Image of trial facility.

IMA203

for Skin Cancer

This clinical trial is a prospective, multicenter, open-label, randomized, actively controlled, parallel-group Phase 3 clinical trial to evaluate the efficacy, safety and tolerability of treatment with IMA203 administered at the recommended phase 2 dose versus investigator's choice of treatment in patients with previously treated, unresectable or metastatic cutaneous melanoma.

Recruiting

2 awards

Phase 3

6 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Huntsman Cancer Institute/University of Utah?

Where is Huntsman Cancer Institute/University of Utah located?

Who should I call to ask about financial aid or insurance network?

What insurance does Huntsman Cancer Institute/University of Utah accept?

What awards or recognition has Huntsman Cancer Institute/University of Utah received?